Designed to penetrate: Time-resolved interaction of single antibiotic molecules with bacterial pores

Membrane permeability barriers are among the factors contributing to the intrinsic resistance of bacteria to antibiotics. We have been able to resolve single ampicillin molecules moving through a channel of the general bacterial porin, OmpF (outer membrane protein F), believed to be the principal pathway for the β-lactam antibiotics. With ion channel reconstitution and high-resolution conductance recording, we find that ampicillin and several other efficient penicillins and cephalosporins strongly interact with the residues of the constriction zone of the OmpF channel. Therefore, we hypothesize that, in analogy to substrate-specific channels that evolved to bind certain metabolite molecules, antibiotics have “evolved” to be channel-specific. Molecular modeling suggests that the charge distribution of the ampicillin molecule complements the charge distribution at the narrowest part of the bacterial porin. Interaction of these charges creates a region of attraction inside the channel that facilitates drug translocation through the constriction zone and results in higher permeability rates.

[1]  G. Rolinson,et al.  Microbiological Studies on a New Broad-spectrum Penicillin, “Penbritin”* , 1961, British medical journal.

[2]  J. Hou,et al.  The amino acid nature of ampicillin and related penicillins. , 1969, Journal of pharmaceutical sciences.

[3]  E Neher,et al.  Conductance fluctuations and ionic pores in membranes. , 1977, Annual review of biophysics and bioengineering.

[4]  H. Nikaido,et al.  Specificity of diffusion channels produced by lambda phage receptor protein of Escherichia coli. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Nikaido,et al.  Porin channels in Escherichia coli: studies with beta-lactams in intact cells , 1983, Journal of bacteriology.

[6]  F. Yoshimura,et al.  Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12 , 1985, Antimicrobial Agents and Chemotherapy.

[7]  H. Nikaido,et al.  Sensitivity of Escherichia coli to various β‐lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β‐lactamases: a quantitative predictive treatment , 1987, Molecular microbiology.

[8]  H. Nikaido Outer membrane barrier as a mechanism of antimicrobial resistance , 1989, Antimicrobial Agents and Chemotherapy.

[9]  G. Schulz,et al.  The three‐dimensional structure of porin from Rhodobacter capsulatus at 3 Å resolution , 1990, FEBS letters.

[10]  G. Schulz,et al.  Molecular architecture and electrostatic properties of a bacterial porin. , 1991, Science.

[11]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[12]  G. Rummel,et al.  Crystal structures explain functional properties of two E. coli porins , 1992, Nature.

[13]  H. Nikaido,et al.  Prevention of drug access to bacterial targets: permeability barriers and active efflux. , 1994, Science.

[14]  G. Rummel,et al.  Structural and functional alterations of a colicin-resistant mutant of OmpF porin from Escherichia coli. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Ash Antibiotic resistance: the new apocalypse? , 1996, Trends in microbiology.

[16]  D. Branton,et al.  Characterization of individual polynucleotide molecules using a membrane channel. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Hancock,et al.  The bacterial outer membrane as a drug barrier. , 1997, Trends in microbiology.

[18]  G. Schulz,et al.  Energy profile of maltooligosaccharide permeation through maltoporin as derived from the structure and from a statistical analysis of saccharide‐protein interactions , 1997, Protein science : a publication of the Protein Society.

[19]  Tilman Schirmer General and specific porins from bacterial outer membranes. , 1998, Journal of structural biology.

[20]  P. H. Trnobranski Are we facing a 'post-antibiotic era'?--a review of the literature regarding antimicrobial drug resistance. , 1998, Journal of clinical nursing.

[21]  G. Rolinson Forty years of beta-lactam research. , 1998, The Journal of antimicrobial chemotherapy.

[22]  S. Bezrukov,et al.  ATP transport through a single mitochondrial channel, VDAC, studied by current fluctuation analysis. , 1998, Biophysical journal.

[23]  J. Frère,et al.  When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with β‐lactams , 1999, Molecular microbiology.

[24]  Mathias Winterhalter,et al.  Reconstitution of Channel Proteins in (Polymerized) ABA Triblock Copolymer Membranes , 2000 .

[25]  J. Pagés,et al.  Substitutions in the Eyelet Region Disrupt Cefepime Diffusion through the Escherichia coli OmpF Channel , 2000, Antimicrobial Agents and Chemotherapy.

[26]  S. Bezrukov,et al.  Ion Channels as Molecular Coulter Counters to Probe Metabolite Transport , 2000, The Journal of Membrane Biology.

[27]  C. Walsh Molecular mechanisms that confer antibacterial drug resistance , 2000, Nature.

[28]  S. Bezrukov,et al.  Positive cooperativity without domains or subunits in a monomeric membrane channel. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Bayley,et al.  Stochastic sensors inspired by biology , 2001, Nature.

[30]  Lisen Kullman,et al.  Transport of maltodextrins through maltoporin: a single-channel study. , 2002, Biophysical journal.